BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35359617)

  • 1. Biophysical methods in early drug discovery.
    Holdgate G; Embrey K; Milbradt A; Davies G
    ADMET DMPK; 2019; 7(4):222-241. PubMed ID: 35359617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysics in drug discovery: impact, challenges and opportunities.
    Renaud JP; Chung CW; Danielson UH; Egner U; Hennig M; Hubbard RE; Nar H
    Nat Rev Drug Discov; 2016 Oct; 15(10):679-98. PubMed ID: 27516170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical methods in drug discovery from small molecule to pharmaceutical.
    Holdgate G; Geschwindner S; Breeze A; Davies G; Colclough N; Temesi D; Ward L
    Methods Mol Biol; 2013; 1008():327-55. PubMed ID: 23729258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Native Mass Spectrometry Screening in Drug Discovery.
    Gavriilidou AFM; Sokratous K; Yen HY; De Colibus L
    Front Mol Biosci; 2022; 9():837901. PubMed ID: 35495635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biophysical Analysis of the Protein-Small Molecule Interactions to Develop Small Molecule Drug Discovery].
    Nagatoishi S; Caaveiro JMM; Tsumoto K
    Yakugaku Zasshi; 2018; 138(8):1033-1041. PubMed ID: 30068844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A
    Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences in fragment-based lead discovery.
    Hubbard RE; Murray JB
    Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Familiar Protein-Ligand Interaction Revisited with Multiple Methods.
    Li-Blatter X; Zweifel L; Sharpe T
    Methods Mol Biol; 2021; 2263():47-79. PubMed ID: 33877593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscale thermophoresis for the assessment of nuclear protein-binding affinities.
    Zhang W; Duhr S; Baaske P; Laue E
    Methods Mol Biol; 2014; 1094():269-76. PubMed ID: 24162995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characterization of protein interactions - what, how and how much?
    Walport LJ; Low JKK; Matthews JM; Mackay JP
    Chem Soc Rev; 2021 Nov; 50(22):12292-12307. PubMed ID: 34581717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-stage biophysical screening cascade for fragment-based drug discovery.
    Mashalidis EH; Śledź P; Lang S; Abell C
    Nat Protoc; 2013 Nov; 8(11):2309-24. PubMed ID: 24157549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMSO-Related Effects on Ligand-Binding Properties of Lysine Methyltransferases G9a and SETD8.
    Feoli A; Sarno G; Castellano S; Sbardella G
    Chembiochem; 2024 Feb; 25(4):e202300809. PubMed ID: 38205880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-bead, single-molecule, single-cell fluorescence: technologies for drug screening and target validation.
    Hintersteiner M; Auer M
    Ann N Y Acad Sci; 2008; 1130():1-11. PubMed ID: 18596327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-free characterization of carbonic anhydrase-novel inhibitor interactions using surface plasmon resonance, isothermal titration calorimetry and fluorescence-based thermal shift assays.
    Rogez-Florent T; Duhamel L; Goossens L; Six P; Drucbert AS; Depreux P; Danzé PM; Landy D; Goossens JF; Foulon C
    J Mol Recognit; 2014 Jan; 27(1):46-56. PubMed ID: 24375583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of
    Nagatoishi S; Yamaguchi S; Katoh E; Kajita K; Yokotagawa T; Kanai S; Furuya T; Tsumoto K
    Bioorg Med Chem; 2018 May; 26(8):1929-1938. PubMed ID: 29510947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.